This is an old revision of this page, as edited by Jytdog (talk | contribs) at 18:22, 11 October 2016 (ethicon). The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.
Revision as of 18:22, 11 October 2016 by Jytdog (talk | contribs) (ethicon)(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)Company type | Private |
---|---|
Industry | Health informatics and medical technology |
Founded | London, United Kingdom |
Founders | Advait Gandhe, Jean Nehme, Andre Chow, Sanjay Purkayastha |
Headquarters | London and New York City |
Key people | Jean Nehme, M.D. (CEO), Andre Chow, M.D.,(COO) |
Products | Medical education Medical technology |
Website | Official website |
Touch Surgery is a London and New York City-based health technology app and trading name for the company Kinosis LTD. The company was co-founded by Advait Gandhe, Jean Nehme, Andre Chow, and Sanjay Purkayastha in 2011. The Touch Surgery mobile app is a mobile surgical training platform designed to simulate surgical procedures. As of August 2014, The Touch Surgery mobile app included surgical instructions for about 50 surgical procedures. As of 2014 the company claimed patients make about forty percent of the app's downloads. In August 2016 Touch partnered with Ethicon Inc. to provide training for Ethicon's surgical products.
References
- ^ "Touch Surgery: the iPad app that teaches surgeons how to operate," by Oliver Wainwright, The Guardian, February 27, 2013, retrieved March 18, 2015.
- "About Us," Touch Surgery official website, retrieved March 18, 2015.
- "Surgeons develop app to practise surgery," by Parul Agrawal, BBC News, June 15, 2013, retrieved March 19, 2015.
- ^ "Touch Surgery: learning surgery on the operating table," by Joao Mederios, Wired, July 28, 2014, retrieved March 18, 2014.
- "Operations," Touch Surgery website, retrieved March 19, 2015.
- Al Idrus, Amirah (August 24, 2016). "J&J's Ethicon teams up with Touch Surgery on virtual surgical training". FierceBiotech.